TriSalus Life Sciences Affirms FY2026 Sales Guidance of $54.000M-$57.000M vs $52.396M Est

Benzinga Newsdesk www.benzinga.com Negative 67.3%

Neg 67.3% Neu 0% Pos 0%

TriSalus Life Sciences (NASDAQ:TLSI) affirms FY2026 sales outlook from $54.000 million-$57.000 million to $54.000 million-$57.000 million vs $52.396 million estimate.